#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14270	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2090	677.2	0	.	n	.	0	C451T	SNP	451	451	C	705	705	T	762	T,C	391,329	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14270	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2090	677.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1438	1438	C	858	C	813	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25986	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3429	754.1	0	.	n	.	0	T695C	SNP	695	695	T	951	951	C	792	C	742	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25986	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3429	754.1	0	.	n	.	0	A1638G	SNP	1638	1638	A	1894	1894	G	821	G,A	562,210	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25986	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3429	754.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2227	2227	C	837	C,A	785,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25986	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3429	754.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2301	2301	A	871	A,G	825,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25986	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3429	754.1	1	SNP	n	C2597T	0	.	.	2597	2597	C	2853	2853	C	826	C	779	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25986	23S	2890	2890	99.9	23S.l6.c30.ctg.1	3429	754.1	0	HET	.	.	.	G1571A	.	1571	1571	G	1827	1827	G	805	G,A	584,172	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	1776	folP	855	855	100.0	folP.l6.c30.ctg.1	1592	110.8	1	SNP	p	R229S	1	.	.	685	687	AGC	945	947	AGC	186;186;188	A;G;C	175;172;175	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4978	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3518	141.3	1	SNP	p	S91F	1	.	.	271	273	TTC	607	609	TTC	176;174;172	T;T;C	166;163;162	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4978	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3518	141.3	1	SNP	p	G95N	0	.	.	283	285	GGC	619	621	GGC	172;173;171	G;G;C	160;160;159	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4978	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3518	141.3	1	SNP	p	D95G	1	.	.	283	285	GGC	619	621	GGC	172;173;171	G;G;C	160;160;159	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	1506	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1363	109.6	1	SNP	p	G45D	0	.	.	133	135	GGC	506	508	GGC	195;192;189	G;G;C	177;173;171	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	694	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c30.ctg.1	846	80.7	0	.	n	.	0	A197.	DEL	197	197	A	497	497	A	180	A	169	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5224	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2944	176.7	1	SNP	p	D86N	0	.	.	256	258	GAC	581	583	GAC	196;195;196	G;A;C	184;182;184	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5224	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2944	176.7	1	SNP	p	R87W	0	.	.	259	261	CGT	584	586	CGT	202;205;206	C;G;T	192;195;195	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5224	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2944	176.7	1	SNP	p	R87I	0	.	.	259	261	CGT	584	586	CGT	202;205;206	C;G;T	192;195;195	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5224	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2944	176.7	1	SNP	p	S87R	1	.	.	259	261	CGT	584	586	CGT	202;205;206	C;G;T	192;195;195	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5224	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2944	176.7	1	SNP	p	S88P	0	.	.	262	264	TCC	587	589	TCC	207;207;210	T;C;C	193;191;199	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3760	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2516	148.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1472	1474	GGC	208;207;208	G;G;C	196;193;193	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3814	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2439	155.5	1	SNP	p	A311V	0	.	.	931	933	GCC	1290	1292	GCC	222;220;219	G;C,T;C	206;204,1;205	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3814	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2439	155.5	1	SNP	p	I312M	1	.	.	934	936	ATG	1293	1295	ATG	220;223;224	A,C;T;G	204,1;208;207	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3814	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2439	155.5	1	SNP	p	T316P	0	.	.	946	948	ACC	1305	1307	ACC	219;220;220	A;C;C	196;198;197	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3814	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2439	155.5	1	SNP	p	V316T	1	.	.	946	948	ACC	1305	1307	ACC	219;220;220	A;C;C	196;198;197	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3814	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2439	155.5	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1806	1808	ACC	215;217;216	A;C;C,T	192;200;200,1	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3814	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2439	155.5	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1860	1862	GCG	206;204;203	G;C;G	193;191;191	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3814	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2439	155.5	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1860	1862	GCG	206;204;203	G;C;G	193;191;191	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3814	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2439	155.5	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1983	1985	GGT	144;144;146	G;G;T	133;133;135	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3814	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2439	155.5	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1992	1994	AGC	136;136;137	A;G;C	129;129;127	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3814	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2439	155.5	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2010	2012	CCG	135;140;138	C,G;C,G;G	103,6;110,1;108	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5414	ponA	2397	2397	100.0	ponA.l15.c30.ctg.1	3213	168.0	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1651	1653	CCG	192;193;189	C;C;G	176;179;171	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2294	porA	1146	1146	99.91	porA.l6.c17.ctg.1	1888	120.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	549	549	C	149	C	136	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2582	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1612	159.3	0	.	p	.	0	G210R	NONSYN	628	630	GGA	953	955	AGA	199;199;196	A;G;A	183;182;179	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2582	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1612	159.3	0	.	p	.	0	S217G	NONSYN	649	651	AGT	974	976	GGT	195;196;198	G;G;T	179;181;182	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2582	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1612	159.3	0	.	p	.	0	G252E	NONSYN	754	756	GGA	1079	1081	GAA	199;201;203	G;A;A	192;193;195	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2582	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1612	159.3	1	SNP	p	G120K	1	.	.	358	360	AAG	683	685	AAG	202;201;202	A;A;G	186;189;185	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2582	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1612	159.3	1	SNP	p	A121N	1	.	.	361	363	AAC	686	688	AAC	203;201;197	A;A;C	189;189;184	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2582	porB1b	1038	1038	99.71	porB1b.l6.c4.ctg.1	1612	159.3	1	SNP	p	N121D	0	.	.	361	363	AAC	686	688	AAC	203;201;197	A;A;C	189;189;184	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10398	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4765	217.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1166	rpsJ	312	312	100.0	rpsJ.l6.c30.ctg.1	1003	115.4	1	SNP	p	V57M	1	.	.	169	171	ATG	497	499	ATG	231;232;232	A;T,C;G	217;216,1;221	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
